Summary
Clinical trials and studies generate vast amounts of high-quality data, yet it is rarely returned to the people taking part in the trial. Furthermore, the data is typically siloed in separate repositories and cannot be used for other studies.
The aim of FACILITATE is to develop a prototype of a patient-centered, data-driven process that would allow innovative data sharing and the re-use and return of clinical trial data to study participants. The prototype process will be built within an approved ethical framework that respects the EU’s General Data Protection Regulation (GDPR).
The consortium comprises a wide range of stakeholders, including patients, healthcare professionals, software designers, processors and controllers of clinical trial repositories, ethicists, and lawyers. Together, they will build a trusted ethical, legal and regulatory ecosystem to provide clear rules for all stakeholders before engaging patients as data generators. Among other things, here the project will focus on asking study participants what they would need to feel part of a trusted ecosystem.
FACILITATE will then generate technological solutions to allow data to be shared and re-used, based on the ‘empowered willingness’ of patients. With patient consent, FACILITATE will be able to re-use and cross-reference data with data contained in other repositories including real world evidence (RWE) data captured across multiple settings and devices.
Ultimately, FACILITATE offers a concrete opportunity to modify the current healthcare paradigm, by putting patient participation at the centre of the development of health research, and give patients the confidence to shift from a passive receiver of care to an active, responsible, and aware driver of their own health.
Achievements & News
February 2022
The last Innovative Medicines Initiative (IMI) project to launch, FACILITATE will explore how we can return data from clinical trials...
Participants
Show participants on mapEFPIA companies
- Abbvie Inc, North Chicago, Illinois, United States
- Almirall SA, Barcelona, Spain
- Astrazeneca AB, Södertälje, Sweden
- Bayer Aktiengesellschaft, Leverkusen, Germany
- Bristol-Myers Squibb Company Corp, Princeton, NJ, United States
- F. Hoffmann-La Roche AG, Basel, Switzerland
- Institut De Recherches Servier, Suresnes, France
- Mdsol Europe LTD, London, United Kingdom
- Pfizer Limited, Sandwich, Kent , United Kingdom
- Sanofi-Aventis Recherche & Developpement, Chilly Mazarin, France
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon (Zurich), Switzerland
Universities, research organisations, public bodies, non-profit groups
- Accademia Europea Di Bolzano, Bolzano, Italy
- Azienda Ospedaliera Universitaria Policlinico Di Modena, Modena, Italy
- Institut Za Medicinska Istra Ivanja, Belgrade, Serbia
- Medizinische Universitat Graz, Graz, Austria
- Spitalul Clinic Colentina Bucuresti, Bucuresti, Romania
- Universita Degli Studi Di Modena E Reggio Emilia, Modena, Italy
- Vrije Universiteit Brussel, Brussel, Belgium
Small and medium-sized enterprises (SMEs) and mid-sized companies (<€500 m turnover)
- Adera SAS, Pessac, France
- Odysseus Data Services Sro, Praha, Czech Republic
- Privanova SAS, Paris, France
- Privredno Drustvo Zentrix Lab Drustvo SA Ogranicenom Odgovornoscu Pancevo, Pancevo, Serbia
- St Antonius Hospital Gronau GMBH, Gronau, Germany
- Tampereen Korkeakoulusaatio Sr, Tampere, Finland
Patient organisations
- Accademia Del Paziente Esperto Eupati Aps, Roma, Italy
- Ass Cittadinanzattiva Aps, Roma, Italy
- Eurordis - Rare Diseases Europe, Paris, France
- Uniwersytet Jagiellonski, Krakow, Poland
Third parties
- Inpeco Tpm SRL, Pula (CA), Italy
Non EFPIA companies
- Inpeco SA, Novazzano, Switzerland
Participants | |
---|---|
Name | EU funding in € |
Accademia Del Paziente Esperto Eupati Aps | 75 997 |
Accademia Europea Di Bolzano | 275 250 |
Adera SAS | 91 500 |
Ass Cittadinanzattiva Aps | 175 225 |
Azienda Ospedaliera Universitaria Policlinico Di Modena | 72 500 |
Eurordis - Rare Diseases Europe | 140 250 |
Institut Za Medicinska Istra Ivanja | 83 063 |
Medizinische Universitat Graz | 134 625 |
Odysseus Data Services Sro | 381 625 |
Privanova SAS | 290 000 |
Privredno Drustvo Zentrix Lab Drustvo SA Ogranicenom Odgovornoscu Pancevo | 268 375 |
Spitalul Clinic Colentina Bucuresti | 54 675 |
St Antonius Hospital Gronau GMBH | 87 939 |
Stichting Eupati Foundation (left the project) | 6 128 |
Tampereen Korkeakoulusaatio Sr | 215 250 |
Universita Degli Studi Di Modena E Reggio Emilia | 592 349 |
Uniwersytet Jagiellonski | 77 750 |
Vrije Universiteit Brussel | 237 500 |
Total Cost | 3 260 001 |